TITLE

Helicobacter pylon and antibiotic resistance

AUTHOR(S)
Megraud, Francis
PUB. DATE
November 2007
SOURCE
Gut;Nov2007, Vol. 56 Issue 11, p1502
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information about the Gut tutorial "Helicobacter pylori and antibiotic resistance," available on the website BMJ Learning. Helicobacter pylori is a Gram-negative flagellated spiral bacteria causing infection mainly in children. Resistance to antibiotics is stresses upon as it can lead to treatment failure.
ACCESSION #
27560492

 

Related Articles

  • Helicobacter Pylori Infection in Children. Rajindrajith, Shaman; Devanarayana, Niranga M.; De Silva, Hithanadura Janaka // Saudi Journal of Gastroenterology;Apr2009, Vol. 15 Issue 2, p86 

    Helicobacter pylori infection is a common problem in pediatric practice, and its acquisition is related with poor socioeconomic conditions. Although the organism is thought to be responsible for many diseases, only a handful of them have a direct causal relationship. At present, only a small...

  • Bismuth based regimes should be first line therapy for Helicobacter pylori eradication. Iakovenko, E.P.; Grigoriev, P.; Yakovenko, A.V.; Bikbavova, R.; Anashkin, V.; Anaeva, T.; Aldiyarova, M.; Soluyanova, I. // Gut;Sep2002 Supplement 2, Vol. 51, pA92 

    Increasing of antibiotic resistance of Helicobacter pylori (Hp), ability of bismuth compounds overcome it may have a significant clinical impact on efficacy and choice of current anti-Hp regimens eradication Aim: to compare the eradication rate of Hp-infection in 1997 and in 2001 year (yr) using...

  • Helicobacter pylori Infection, cag A Status, and Duodenal Ulcer Disease in Children. Elitsur, Yoram; Weir, Susan C. // Journal of Infectious Diseases;9/1/2000, Vol. 182 Issue 3, p1007 

    Comments on the article entitled 'Factors associated with Helicobacter pylori infection by a cagA-positive strain in children' which appeared in a 2000 issue of 'The Journal of Infectious Diseases.' Relationship between inflammatory index and the presence of cagA antibody in symptomatic...

  • Reply. de Magalhaes Queiroz, Dulciene Maria; Noguiera, Ana Margarida Miguel Ferreira; Rocha, Gilfone Aguiar; Rocha, Andreia Maria Camargos // Journal of Infectious Diseases;9/1/2000, Vol. 182 Issue 3, p1008 

    Replies on the comment made by Yoram Elitsur concerning the article entitled 'Factors associated with Helicobacter pylori infection by a cagA-positive strain in children' which appeared in the 2000 issue of 'The Journal of Infectious Diseases.' Importance of dietary habits and the evolution of...

  • Ulcer-causing bacterium now detectable by breath test.  // Medical Update;Nov96, Vol. 20 Issue 5, p1 

    Reports that the United States Food & Drug Administration (FDA) has approved the first antibiotic treatment for peptic ulcers. Combining of omeprazole and clarithromycin; Eradication of the Helicobacter pylori infection.

  • Antibiotic-Resistant H. pylori Infection and Its Treatment. Qureshi, Waqar A.; Graham, David Y. // Current Pharmaceutical Design;Oct2000, Vol. 6 Issue 15, p1537 

    Helicobacter pylori infection causes progressive damage to gastric mucosa and results in serious disease such as peptic ulcer disease, MALT lymphoma, or gastric adenocarcinoma in 20% to 30% of patients. The current approach is to make a firm diagnosis, give combination antibiotic and...

  • Response to Yuan and Leontiadis. Basu, P Patrick // American Journal of Gastroenterology;Jul2012, Vol. 107 Issue 7, p1107 

    A letter to the editor is presented in response to the article "Levofloxacin-based three antibiotic regimen for H. pylori eradication," by Y. Yuan, G. I. Leontiadis in the previous issue in 2012.

  • Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori. Moayyedi, Paul; Ragunathan, P. L.; Mapstone, Nic; Axon, Anthony T. R.; Tompkins, David S. // Journal of Gastroenterology;1998, Vol. 33 Issue 2, p160 

    Abstract: Omeprazole 20mg once (o.d.) or twice daily (b.d.), clarithromycin 250mg b.d., and tinidazole 500mg b.d. for 7 days (OCF) is an effective regimen against Helicobacter priori, but the effect of 5-nitroimidazole resistance is unclear. We aimed to evaluate this using the disc diffusion...

  • Studies continue to hone dosing regimens to eradicate H pylori...  // Modern Medicine;Dec96, Vol. 64 Issue 12, p15 

    Reports on the US Food and Drug Administration's approval of three antibiotic combinations to treat Helicobacter pylori infection. Cure rate for the three drug combinations; Side effects; Testing of another regimen in which a second antibiotic is added to clarithromycin.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics